NCT06144853 2026-03-16
The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.
Odense University Hospital
Completed
Clinical Trials
97 trialsNCT00086567 2026-03-09
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
National Institutes of Health Clinical Center (CC)
Completed
NCT03834272 2026-01-16
Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies
Lumicell, Inc.
Phase 1/2 Completed
NCT01226550 2025-12-19
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
Hospices Civils de Lyon
Phase 1/2 Completed
NCT02823860 2025-12-19
BIG-RENAPE
Hospices Civils de Lyon
Phase NA Completed
NCT05644249 2025-09-24
PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer
Vilnius University
Phase NA Completed
NCT04766502 2025-07-24
PIPADN
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT01932125 2025-06-26
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02228889 2025-06-06
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Phase NA Completed
NCT03508570 2025-05-22
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01443260 2025-04-30
A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Genelux Corporation
Phase 1/2 Completed
NCT05340569 2025-03-20
DWI-PDAC
Laval University
Phase NA Completed
NCT01314105 2025-02-13
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
Boehringer Ingelheim
Phase 1 Completed
NCT04034251 2025-02-03
Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05633836 2025-01-24
MicroFluO
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT03663712 2024-11-20
TEMPO
Duke University
Phase 1 Completed
NCT04950166 2024-11-08
A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets
OncoNano Medicine, Inc.
Phase 2 Completed
NCT02040142 2024-10-24
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Phase 2 Completed
NCT02891447 2024-09-19
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02903771 2024-09-19
Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Kazia Therapeutics Limited
Phase 1 Completed
NCT03777943 2024-09-19
MMT
University Hospital, Ghent
Completed
NCT04744688 2024-05-29
CONTEST
University of Aarhus
Completed
NCT04252560 2024-05-09
The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.
Uppsala University Hospital
Completed
NCT06237582 2024-02-01
OvEpiLyPath
Jules Bordet Institute
Phase NA Completed
NCT02399410 2024-01-30
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis
University Hospital, Ghent
Phase 2 Completed
NCT03517852 2024-01-19
Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC)
Mayo Clinic
Phase NA Completed
NCT03618758 2023-12-05
IPLUS
Seoul National University Bundang Hospital
Phase 1/2 Completed
NCT02567253 2023-11-27
OvIP1
University Hospital, Ghent
Phase 2 Completed
NCT03038100 2023-02-17
IMagyn050
Hoffmann-La Roche
Phase 3 Completed
NCT02759588 2023-01-05
GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer
Genelux Corporation
Phase 1/2 Completed
NCT05547568 2022-10-21
A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?
CHU de Reims
Completed
NCT03287375 2022-10-07
PIPAC-OPC2
Odense University Hospital
Phase 2 Completed
NCT01462890 2022-07-20
BOOST
AGO Study Group
Phase 3 Completed
NCT02179489 2022-06-27
Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Zhejiang University
Phase NA Completed
NCT02833753 2022-05-31
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
University of Massachusetts, Worcester
Phase 1 Completed
NCT05300789 2022-03-29
Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients
Hospital San Carlos, Madrid
Completed
NCT02158988 2021-07-29
GASTRIPEC
Charite University, Berlin, Germany
Phase 3 Completed
NCT04879953 2021-05-11
Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin
Association Francaise de Chirurgie
Completed
NCT03561948 2021-03-19
Feasibility of Intraperitoneal Chemotherapy in the Surgical Treatment of Colon Cancer cT4
State Scientific Centre of Coloproctology, Russian Federation
Phase NA Completed
NCT03593681 2021-01-20
nCYT
Boston Scientific Corporation
Completed
NCT00262990 2020-12-17
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Novartis
Phase 3 Completed
NCT00216372 2020-11-05
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Ipsen
Phase 3 Completed
NCT02784028 2020-10-20
FLUOCAR-1
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT00391118 2020-10-19
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
Eli Lilly and Company
Phase 2 Completed
NCT02604784 2020-09-17
PI-CaP
Fondazione del Piemonte per l'Oncologia
Phase 1/2 Completed
NCT02151448 2020-07-20
αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
University of Pittsburgh
Phase 1/2 Completed
NCT02082886 2020-01-29
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry
Edward-Elmhurst Health System
Completed
NCT04122937 2019-11-25
CarFlog
University of Pisa
Completed
NCT01478685 2019-11-12
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Celgene
Phase 1 Completed
NCT03246321 2019-10-15
CRC-PIPAC
Catharina Ziekenhuis Eindhoven
Phase 2 Completed